In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
UK reports of persistent sexual dysfunction after discontinuation of finasteride
Since the first report was received in November 1992, the UK’s MHRA has received 426 Yellow Card reports up until 5 April 2024 of finasteride (both 1mg and 5mg formulations) and sexual dysfunction, including reports of erectile dysfunction and decreased sex drive. In almost half of these reports, the outcome was recorded as ‘not recovered’ or ‘not resolved’.
UK reports of psychiatric dysfunction with finasteride
Since the first report was received in February 1993, the UK’s MHRA has received 281 reports of finasteride and depressed mood disorders and suicidal and self-injurious behaviours, up until 5 April 2024.
Please login to view the rest of this drug profile.